Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EA
1226
PUT
DELISTED
Electronic Arts
EA
| $12.7M | 0.01% |
79,500
-285,000
| -78% | -$42.1M |
|
1227
Magna International
MGA
$18.8B
| $12.7M | 0.01% |
328,543
+108,082
| +49% | +$3.82M |
|
1228
PUT
Vertex Pharmaceuticals
VRTX
$135B
| $12.6M | 0.01% |
28,300
+19,900
| +237% | +$9.17M |
|
1229
PUT
Cencora
COR
$61.9B
| $12.6M | 0.01% |
42,000
-6,000
| -13% | -$1.73M |
|
1230
CALL
American Express
AXP
$228B
| $12.6M | 0.01% |
39,400
+15,000
| +61% | +$4.22M |
|
1231
NovoCure
NVCR
$2.03B
| $12.6M | 0.01% |
705,646
+620,947
| +733% | +$10.8M |
|
1232
CALL
Abbott
ABT
$188B
| $12.5M | 0.01% |
92,000
+44,000
| +92% | +$5.8M |
|
1233
PUT
Eaton
ETN
$174B
| $12.5M | 0.01% |
+35,000
| New | +$10.8M |
|
1234
iShares MSCI China ETF
MCHI
$6.41B
| $12.5M | 0.01% |
226,745
-9,560
| -4% | -$508K |
|
1235
Enterprise Products Partners
EPD
$82B
| $12.5M | 0.01% |
402,553
+41,426
| +11% | +$1.29M |
|
1236
CALL
CSX Corp
CSX
$93B
| $12.4M | 0.01% |
381,500
+64,700
| +20% | +$1.95M |
|
1237
Gates Industrial Corporation Ltd.
GTES
$7.14B
| $12.4M | 0.01% |
540,261
+292,043
| +118% | +$5.89M |
|
|
NVO
1238
CALL
Novo Nordisk
NVO
$209B
| $12.4M | 0.01% |
180,000
-115,000
| -39% | -$7.82M |
|
|
EXAS
1239
DELISTED
Exact Sciences
EXAS
| $12.4M | 0.01% |
233,162
-1,048,743
| -82% | -$53.3M |
|
1240
Berkshire Hathaway Class A
BRK.A
$1.15T
| $12.4M | 0.01% |
17
| – | – |
|
1241
Vanguard International High Dividend Yield ETF
VYMI
$21.2B
| $12.4M | 0.01% |
154,330
+7,472
| +5% | +$572K |
|
1242
Ibotta
IBTA
$738M
| $12.3M | 0.01% |
337,154
+2,694
| +0.8% | +$126K |
|
1243
PUT
Cadence Design Systems
CDNS
$93.2B
| $12.3M | 0.01% |
+40,000
| New | +$11.6M |
|
1244
PUT
Synopsys
SNPS
$79.8B
| $12.3M | 0.01% |
+24,000
| New | +$11.2M |
|
1245
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
| $12.3M | 0.01% |
295,508
+295,450
| +509,397% | +$12.1M |
|
1246
iShares MSCI Mexico ETF
EWW
$1.91B
| $12.3M | 0.01% |
202,931
-22,535
| -10% | -$1.3M |
|
|
DOCU
1247
DocuSign
DOCU
$11.6B
| $12.3M | 0.01% |
157,689
-113,460
| -42% | -$9.18M |
|
1248
Banco Santander
SAN
$210B
| $12.3M | 0.01% |
1,479,348
-870,219
| -37% | -$6.47M |
|
1249
American Homes 4 Rent
AMH
$12.2B
| $12.2M | 0.01% |
339,580
+163,495
| +93% | +$6.05M |
|
1250
United Therapeutics
UTHR
$22.5B
| $12.2M | 0.01% |
42,534
-27,804
| -40% | -$8.31M |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.